Pre-treatment verification of lung SBRT VMAT plans with delivery errors: Toward a better understanding of the gamma index analysis

Commonly adopted gamma criteria are not sensitive enough to validate lung SBRT VMAT plans at the 2% dose difference level. The error detection levels are fairly consistent despite changes in gamma criteria and cut-offs. The choice of gamma criteria was not significant and there was no clear benefit in tightening the gamma criteria.